Azenta Inc
NASDAQ:AZTA

Watchlist Manager
Azenta Inc Logo
Azenta Inc
NASDAQ:AZTA
Watchlist
Price: 50.25 USD 0.44%
Market Cap: 2.3B USD
Have any thoughts about
Azenta Inc?
Write Note

Azenta Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Azenta Inc
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Azenta Inc
NASDAQ:AZTA
Other Equity
-$13.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Other Equity
-$2.5B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
-13%
Danaher Corp
NYSE:DHR
Other Equity
-$1.3B
CAGR 3-Years
-7%
CAGR 5-Years
16%
CAGR 10-Years
-52%
Mettler-Toledo International Inc
NYSE:MTD
Other Equity
-$327.8m
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
-16%
Agilent Technologies Inc
NYSE:A
Other Equity
-$305m
CAGR 3-Years
-3%
CAGR 5-Years
10%
CAGR 10-Years
1%
IQVIA Holdings Inc
NYSE:IQV
Other Equity
-$826m
CAGR 3-Years
-23%
CAGR 5-Years
-17%
CAGR 10-Years
-41%
No Stocks Found

Azenta Inc
Glance View

Market Cap
2.3B USD
Industry
Life Sciences Tools & Services

Azenta Inc. emerged as a focused entity after the strategic divestiture of Brooks Automation's semiconductor business, carving out a niche to serve the life sciences industry with precision. The company's evolution is a testament to its strategic agility, aligning itself with the burgeoning demand for data-driven decision-making in healthcare and biotechnology. Azenta specializes in providing comprehensive solutions that revolve around sample management, genomic services, and automated storage systems. By ensuring the integrity and accessibility of biological samples and data, Azenta plays a crucial role in accelerating research and development processes. Its core operations are built upon intricate platforms that manage critical laboratory activities and genomic sequencing, enabling laboratories and research institutions to streamline their workflows and enhance productivity. Central to Azenta's business model is its recurring revenue stream derived from life science products and services, which supports labs in safeguarding and optimizing essential research materials. The company's offerings encompass robust automated systems, state-of-the-art genomic services, and logistics that ensure seamless sample management from collection to analysis. Through strategic partnerships and continuous innovation, Azenta effectively supports its clients in navigating the complexities of modern research, ultimately helping translate scientific endeavors into tangible outcomes. By continually expanding its technological capabilities and service offerings, Azenta not only fortifies its market position but also underscores its commitment to facilitating transformative advancements in life science and healthcare industries.

AZTA Intrinsic Value
34.23 USD
Overvaluation 32%
Intrinsic Value
Price

See Also

What is Azenta Inc's Other Equity?
Other Equity
-13.5m USD

Based on the financial report for Sep 30, 2024, Azenta Inc's Other Equity amounts to -13.5m USD.

What is Azenta Inc's Other Equity growth rate?
Other Equity CAGR 1Y
78%

Over the last year, the Other Equity growth was 78%.

Back to Top